Don Soland
Direktor/Vorstandsmitglied bei DBV TECHNOLOGIES
Vermögen: 493 695 $ am 31.07.2023
Aktive Positionen von Don Soland
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 06.03.2015 | - |
| Independent Dir/Board Member | 06.03.2015 | - | |
| ACADIA PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 26.03.2015 | - |
| Independent Dir/Board Member | 20.03.2015 | - |
Karriereverlauf von Don Soland
Ehemalige bekannte Positionen von Don Soland
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Geschäftsführer | 04.01.2020 | 28.09.2022 |
| KALVISTA PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 22.04.2019 | 26.05.2022 |
| Independent Dir/Board Member | 22.04.2019 | 26.05.2022 | |
| UNIQURE N.V. | Direktor/Vorstandsmitglied | 15.06.2016 | 22.09.2016 |
| Vorstandsvorsitzender | 31.12.2015 | 22.09.2016 | |
| OXFORD BIOMEDICA PLC | Direktor/Vorstandsmitglied | 07.05.2015 | 05.01.2016 |
| Viropharma, Inc. | Geschäftsführer | 01.03.2008 | 01.12.2014 |
| Corporate Officer/Principal | 01.01.2006 | 01.03.2008 | |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Geschäftsführer | 01.11.2006 | 01.02.2014 |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Präsident | 01.02.2005 | 01.06.2006 |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Don Soland
| University of Iowa | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 11 |
| Vereinigtes Königreich | 3 |
| Frankreich | 2 |
Operativ
| Director/Board Member | 6 |
| Chief Operating Officer | 3 |
| Independent Dir/Board Member | 3 |
Sektoral
| Health Technology | 13 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| UNIQURE N.V. | Health Technology |
| KALVISTA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Seqirus Vaccines Ltd.
Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Epigenesis Pharmaceuticals LLC develops inhaled respiratory medicines. It also provides treatments for the asthma, obstructive pulmonary disease and other respiratory diseases. The company was founded by Jonathan W. Nyce in 1995 and is headquartered in Cranbury, NJ. | Health Technology |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
| Viropharma, Inc. |
- Börse
- Insiders
- Don Soland
- Erfahrung
